FOUNDED | 2020


Richard Henson, CEO
Dr. Tali Konry, CSO



Viral testing has received significant attention with the rise of the COVID-19 pandemic. A fast-acting test that can be rapidly deployed in remote locations can make the difference between containing an outbreak and widespread infection. NeorahDX has developed a diagnostic test kit for detecting COVID-19 that does not require capital equipment to produce accurate results. The test kit uses a colorimetric design making it easy for technicians to determine test results at the site where the sample was taken. The versatile and fast-acting nature of NeorahDX’s design brings rapid testing capabilities to places where they are needed most.